Latest News

Circulating tumor cell count may serve as a prognostic biomarker in mHSPC
Circulating tumor cell count may serve as a prognostic biomarker in mHSPC

October 8th 2024

Patients with elevated CTC count at baseline experienced poor complete response rates and worsened PFS and OS.

FDA approves study of Aquablation vs radical prostatectomy in prostate cancer
FDA approves study of Aquablation vs radical prostatectomy in prostate cancer

October 8th 2024

Benign Prostatic Hyperplasia | Image Credit: © Judith - stock.adobe.com
Dr. Stephen Overholser shares his experience with Aquablation for BPH

October 8th 2024

Health Canada approves expanded indication of Illuccix in prostate cancer
Health Canada approves expanded indication of Illuccix in prostate cancer

October 7th 2024

Young woman paying bills | Image Credit: © fizkes - stock.adobe.com
Money Matters: Financial considerations when getting married

October 7th 2024

Latest Videos

Latest News

© 2024 MJH Life Sciences

All rights reserved.